logo
Select company
Select metric
9.16Current Ratio
VS
Market
92
Sector
82
Industry
74
History
13
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

SAGE

Company Name

SAGE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SAGE THERAPEUTICS INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SAGE - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 409.08M9.16$ 44.64M
3/31/2025$ 454.48M9.13$ 49.78M
12/31/2024$ 531.3M7.42$ 71.61M
9/30/2024$ 604.99M10.02$ 60.41M
6/30/2024$ 686.81M9.95$ 69.04M
3/31/2024$ 755.44M12.22$ 61.8M
12/31/2023$ 869.35M10.51$ 82.75M
9/30/2023$ 933.27M7.02$ 133M
6/30/2023$ 1.06B10.99$ 96.81M
3/31/2023$ 1.2B14.21$ 84.69M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SAGE THERAPEUTICS INC's latest trailing twelve months (TTM) Current Ratio stands at 11.71.
  • Over the past 5 years, SAGE THERAPEUTICS INC's average Current Ratio has been 15.87.
  • The median Current Ratio for SAGE THERAPEUTICS INC during this period was 12.85
  • SAGE THERAPEUTICS INC reached its highest Current Ratio over the past 5 years at 33.09.
  • The lowest Current Ratio recorded by SAGE THERAPEUTICS INC in the same timeframe 7.02

SAGE THERAPEUTICS INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
KURA : KURA ONCOLOGY INC 6.16TBPH : THERAVANCE BIOPHARMA INC 6.7NKTR : NEKTAR THERAPEUTICS 2.61ZVRA : ZEVRA THERAPEUTICS INC 7.85LXRX : LEXICON PHARMACEUTICALS INC 4.16ADCT : ADC THERAPEUTICS SA 4.93YMAB : Y-MABS THERAPEUTICS INC 4GOSS : GOSSAMER BIO INC 4.4EYPT : EYEPOINT PHARMACEUTICALS INC 8AUTL : AUTOLUS THERAPEUTICS PLC 8.43

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for SAGE THERAPEUTICS INC is calculated as follows: AssetsC [ $ 698.88M ] / LiabilitesC [ $ 59.66M ]
(=) Current Ratio [ 11.71 ]

SAGE - Current Ratio, Last 5 years

7.02

Minimum

Sep 30, 2023

33.09

Maximum

Mar 31, 2021

15.87

Average

12.85

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44